CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-27 | Kulkarni Samarth Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −25,000 | 179,582 | ||
| 2022-12-28 | Kulkarni Samarth Chief Executive Officer | Option exercise | +25,000 | $19.12 | $478K | 394,111 |
| 2022-12-28 | Kulkarni Samarth Chief Executive Officer | Sale | −20,366 | $40.81 | $831K | 373,745 |
| 2022-12-28 | Kulkarni Samarth Chief Executive Officer | Sale | −4,634 | $41.45 | $192K | 369,111 |
| 2022-12-28 | Kulkarni Samarth Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −25,000 | 204,582 | ||
| 2022-12-06 | Kulkarni Samarth Chief Executive Officer | Option exercise | +58,233 | $1.81 | $105K | 369,111 |
| 2022-12-06 | Kulkarni Samarth Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −58,233 | 0 | ||
| 2022-12-05 | Kulkarni Samarth Chief Executive Officer | Shares withheld for taxes | −19,401 | $52.26 | $1.0M | 310,878 |
| 2022-12-05 | KASINGER JAMES R. General Counsel and Secretary | Shares withheld for taxes | −3,234 | $52.26 | $169K | 50,191 |
| 2022-12-03 | Kulkarni Samarth Chief Executive Officer | Option exercise | +40,000 | 330,279 | ||
| 2022-12-03 | Kulkarni Samarth Chief Executive Officer | Option exercise · Restricted Stock Units | +40,000 | 0 | ||
| 2022-12-03 | KASINGER JAMES R. General Counsel and Secretary | Option exercise | +6,667 | 53,425 | ||
| 2022-12-03 | KASINGER JAMES R. General Counsel and Secretary | Option exercise · Restricted Stock Units | −6,667 | 0 | ||
| 2022-11-28 | Kulkarni Samarth Chief Executive Officer | Option exercise | +25,000 | $19.12 | $478K | 315,279 |
| 2022-11-28 | Kulkarni Samarth Chief Executive Officer | Sale | −17,118 | $53.58 | $917K | 298,161 |
| 2022-11-28 | Kulkarni Samarth Chief Executive Officer | Sale | −5,572 | $54.85 | $306K | 292,589 |
| 2022-11-28 | Kulkarni Samarth Chief Executive Officer | Sale | −2,310 | $55.40 | $128K | 290,279 |
| 2022-11-28 | Kulkarni Samarth Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −25,000 | 229,582 | ||
| 2022-10-26 | Kulkarni Samarth Chief Executive Officer | Option exercise | +19,582 | $16.21 | $317K | 309,861 |
| 2022-10-26 | Kulkarni Samarth Chief Executive Officer | Option exercise | +5,418 | $19.12 | $104K | 315,279 |
Page 19 of 46 · 910 trades